ALK inhibitor capsules produced by biotech pharmaceutical companies for advanced lung cancer management. Acquired by oncology departments in medical centers for oral targeted therapy. Distributed by authorized wholesalers to ensure availability in cancer treatment protocols for patients with specific genetic